Eastwood Bio-Medical Canada Inc. announced earnings results for the third quarter ended July 31, 2021. For the third quarter, the company announced total revenue was CAD 225,240 compared to CAD 184,854 a year ago. Net loss was CAD 176,159 compared to CAD 73,381 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. For the nine months, total revenue was CAD 710,368 compared to CAD 515,297 a year ago. Net loss was CAD 598,212 compared to CAD 576,179 a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.